Novo Nordisk Foundation

Overview

Novo Nordisk is a Danish multinational healthcare and pharmaceutical company founded in 1923 with a mission to drive change to defeat serious chronic diseases, anchored in almost a century of leadership in diabetes care and expanded into obesity, rare diseases and cardiovascular therapies. Headquartered in Denmark and operating in around 80 countries with tens of thousands of employees worldwide, Novo Nordisk focuses on innovative research, development and delivery of life‑changing medicines and health solutions, balancing scientific excellence with global patient access and responsible business practices. The company embraces a Triple Bottom Line philosophy — integrating financial performance with social and environmental responsibility — and is recognised for its sustainable business approach, stakeholder engagement and corporate governance, reflecting its commitment to long‑term value creation for patients, communities and shareholders.


Comments off 5th January 2026
Translate »